Oric Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
This dashboard includes a questions and answers table on Oric Pharmaceuticals Inc. The webpage displays a free Environmental, Social and Governance assessment covering Oric Pharmaceuticals Inc. The ESG score includes 17 UN Sustainable Development Goals including: 'No Poverty', 'Reduced Inequalities' and 'Life on Land'.
Oric Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.7; made up of an environmental score of 2.0, social score of 0.0 and governance score of 3.2.
1.7
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1631 | Viewbix Inc | 1.8 | Low |
| 1631 | dorsaVi Ltd | 1.8 | Low |
| 1682 | Oric Pharmaceuticals Inc | 1.7 | Low |
| 1682 | C4 Therapeutics Inc | 1.7 | Low |
| 1682 | Abcellera Biologics Inc | 1.7 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Oric Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Oric Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Oric Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Oric Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Oric Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Oric Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Oric Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Oric Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Oric Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Oric Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Oric Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Oric Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Oric Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Oric Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Oric Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Oric Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Oric Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Oric Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Oric Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Oric Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Oric Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Oric Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Oric Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Oric Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Oric Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Oric Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Oric Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Oric Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Oric Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Oric Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Oric Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Oric Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Oric Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Oric Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Oric Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Oric Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Oric Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers. The company's lead product candidate is ORIC-101, a small molecule antagonist of the glucocorticoid receptor, which has been linked to resistance to multiple classes of cancer therapeutics across various solid tumors. Its other product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens; ORIC-944, an allosteric inhibitor for prostate cancer; and ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor designed to selectively target epidermal growth factor receptor and human epidermal growth factor receptor 2 with high potency towards exon 20 insertion mutations. The company is also developing multiple precision medicines targeting other cancer resistance mechanisms. It has collaboration and license agreement with Astellas Pharma, Inc.; Voronoi, Inc.; and Mirati Therapeutics, Inc. The company was incorporated in 2014 and is headquartered in South San Francisco, California.